HOOKIPA Pharma (HOOK) Revenue & Revenue Breakdown
HOOKIPA Pharma Revenue Highlights
Latest Revenue (Y)
$20.13M
Main Segment (Y)
Grant
Main Geography (Y)
Grant
HOOKIPA Pharma Revenue by Period
HOOKIPA Pharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $20.13M | 41.27% |
| 2022-12-31 | $14.25M | -22.76% |
| 2021-12-31 | $18.45M | -5.80% |
| 2020-12-31 | $19.58M | 63.99% |
| 2019-12-31 | $11.94M | 56.53% |
| 2018-12-31 | $7.63M | 100.00% |
| 2017-12-31 | - | - |
HOOKIPA Pharma generated $20.13M in revenue during NA 2023, up 41.27% compared to the previous quarter, and up 263.85% compared to the same period a year ago.
HOOKIPA Pharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $36.60M | 394.11% |
| 2023-12-31 | $7.41M | 7.86% |
| 2023-09-30 | $6.87M | 156.33% |
| 2023-06-30 | $2.68M | -15.65% |
| 2023-03-31 | $3.18M | -59.43% |
| 2022-12-31 | $7.83M | 251.03% |
| 2022-09-30 | $2.23M | -18.79% |
| 2022-06-30 | $2.75M | 90.03% |
| 2022-03-31 | $1.45M | -62.90% |
| 2021-12-31 | $3.90M | 0.54% |
| 2021-09-30 | $3.87M | -27.97% |
| 2021-06-30 | $5.38M | 1.45% |
| 2021-03-31 | $5.30M | 2.67% |
| 2020-12-31 | $5.16M | 27.80% |
| 2020-09-30 | $4.04M | -39.57% |
| 2020-06-30 | $6.68M | 80.87% |
| 2020-03-31 | $3.70M | 2.16% |
| 2019-12-31 | $3.62M | 77.53% |
| 2019-09-30 | $2.04M | -49.69% |
| 2019-06-30 | $4.05M | 81.25% |
| 2019-03-31 | $2.23M | -56.00% |
| 2018-12-31 | $5.08M | 167.37% |
| 2018-09-30 | $1.90M | 192.76% |
| 2018-06-30 | $649.00K | 100.00% |
| 2018-03-31 | - | - |
HOOKIPA Pharma generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
HOOKIPA Pharma Revenue Breakdown
HOOKIPA Pharma Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Grant | $300.00K | $600.00K | $800.00K | $700.00K | $800.00K |
HOOKIPA Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant (100.00%).
HOOKIPA Pharma Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| Grant | $600.00K | $800.00K | $700.00K | $800.00K |
HOOKIPA Pharma's latest annual revenue breakdown by geography, as of Dec 22: Grant (100.00%).
HOOKIPA Pharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals | $380.79M | $88.64M |
| HOOK | HOOKIPA Pharma | $20.13M | - |
| MREO | Mereo BioPharma Group | $10.00M | - |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| PDSB | PDS Bio | - | - |
| DAWN | Day One Biopharmaceuticals | - | $8.19M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ELDN | Eledon Pharmaceuticals | - | - |
HOOK Revenue FAQ
What is HOOKIPA Pharma’s yearly revenue?
HOOKIPA Pharma's yearly revenue for 2023 was $20.13M, representing an increase of 41.27% compared to 2022. The company's yearly revenue for 2022 was $14.25M, representing a decrease of -22.76% compared to 2021. HOOK's yearly revenue for 2021 was $18.45M, representing a decrease of -5.80% compared to 2020.
What is HOOKIPA Pharma’s quarterly revenue?
HOOKIPA Pharma's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $36.6M, a 394.11% increase from the previous quarter (Q4 2023), and a 1052.36% increase year-over-year (Q1 2023). HOOK's quarterly revenue for Q4 2023 was $7.41M, a 7.86% increase from the previous quarter (Q3 2023), and a -5.38% decrease year-over-year (Q4 2022).
What is HOOKIPA Pharma’s revenue growth rate?
HOOKIPA Pharma's revenue growth rate for the last 3 years (2021-2023) was 9.11%, and for the last 5 years (2019-2023) was 68.56%.
What are HOOKIPA Pharma’s revenue streams?
HOOKIPA Pharma's revenue streams in c 23 are Grant
What is HOOKIPA Pharma’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of HOOKIPA Pharma was Grant. This segment made a revenue of $300K, representing 100.00% of the company's total revenue.